Tundra Ventures

Tundra Ventures Research Overview Tundra Ventures is a Minneapolis-based pre-seed venture capital firm founded in 2022 by three General Partners: Amanda Heyman (Silicon Valley), Adam Choe (Minneapolis), and Danielle Steer (Minneapolis). The firm invests in early-stage technology and tech-enabled companies across the United States, with a particular emphasis on founders from underrepresented communities — specifically BIPOC, women, non-binary, and LGBTQ+ entrepreneurs. Investment Thesis Tundra Ventures positions itself as a 'Preseed Specialist and Founder Favorite,' seeking founders with unique insight into untapped markets. The firm's thesis rests on three strategic pillars: Wealth — Financial wellness, fintech, and economic empowerment platforms Health — Digital health, medical technology, aging services, and healthcare accessibility Resilience — Consumer-oriented products and services that promote economic resilience, including sustainable goods, food and beverage, clean energy, and community-enabling tech The firm's operational philosophy centers on four differentiating approaches: (1) Accelerator Guidance — providing hands-on support modeled after accelerator methodologies; (2) Overlooked End Users — focusing on underserved consumer segments that mainstream VCs often miss; (3) Uncovering Alpha — identifying opportunities in regions and categories with lower competition for capital; (4) Exquisite Founder-Market Fit — prioritizing founders with lived experience in the problems they are solving. Tundra's GPs bring a rich ecosystem background: Danielle Steer is the Founding Executive Director of Lunar Startups, Minnesota's first inclusive accelerator (77+ companies); Adam Choe was Managing Director of gener8tor MN and Founding Director of gBETA Medtech (with Boston Scientific and Mayo Clinic Ventures partnerships); Amanda Heyman is an attorney with 13+ years advising early-stage startups and is the creator of a proprietary pre-seed fundraising platform. Stage Focus Tundra Ventures invests exclusively at the pre-seed stage, targeting companies with valuations under $6M. The firm positions itself as one of the first institutional checks into a company. They focus on companies with demonstrated MVPs and defensible IP. Check Size Typical investment range: $100K–$500K. Tundra is designed to be the initial institutional investor, often enabling founders to de-risk and attract subsequent seed rounds. Fund Details Fund I was launched in 2022 and had raised $4.1M in capital commitments as of December 2024 (disclosed to the SEC). The fund's target size was reported as approximately $10–20M. The fund invests in US-based companies and excludes Class II and III medical devices. Geographic Focus Tundra Ventures invests nationally across the United States, with a particular emphasis on the Midwest and Southeast — regions that have historically been underserved by coastal venture capital. The firm's partners are based in Minneapolis, MN and Silicon Valley, with a Venture Scout in Los Angeles. Team Amanda Heyman, General Partner (Silicon Valley): Attorney with 13+ years advising early-stage startups. Co-founder of a fantasy soccer startup (raised Series A). Creator of a proprietary pre-seed fundraising platform. Former UN legal expert on organic agriculture. University of Michigan Law School. Super Lawyers Rising Star and award-winning journalist. Adam Choe, General Partner (Minneapolis): Medtech expert with 5+ patents. Former Managing Director, gener8tor MN (led 8 accelerator cohorts). Founding Director, gBETA Medtech (with Boston Scientific and Mayo Clinic Ventures). Pediatric health tech startup founder/CEO. Senior Innovation Fellow at University of Minnesota. Former roles at Nestlé HealthCare and Abbott. Adjunct professor. Danielle Steer, General Partner (Minneapolis): Founding Executive Director of Lunar Startups, Minnesota's first inclusive accelerator, scaled to 77+ companies and revenue-generating status. Data/evaluation specialist, international entrepreneurship expert, SXSW speaker, Global Accelerator Network board member, Twin Cities Business 100 People To Know. Bobak Roshan, Venture Scout (Los Angeles): Attorney-turned-entrepreneur with experience in retail, restaurant, wholesale, e-commerce, and real estate. Portfolio Highlights As of early 2026, Tundra has backed 13+ companies spanning healthcare AI, fintech, sustainable consumer goods, climate tech, and more: Scout (scoutftw.com): Financial wellness platform for student athletes navigating NIL deals Authsnap (authsnap.ai): AI-powered healthcare and insurance authentication (most recent investment, January 2026) Rosarium Health (rosariumhealth.com): Accessible home modification platform for aging adults Oncodea (oncodea.com): AI/ML cancer detection technology TrueToForm (truetoform.fit): AI-powered apparel fit prediction for e-commerce Enspi Technologies (enspi.io): Smart grid / clean energy platform GenEQTY (geneqty.com): Fintech data insights for SMBs Bim Bam Boo (bimbamboopaper.com): Tree-free, sustainable paper products (bamboo-based) Maazah (maazah.com): Afghan-inspired specialty sauces (food & beverage) Playbite (playbite.com): Consumer growth and user acquisition platform We Sparkle (wesparkle.co): AI assistant for destination organizations and tourism Runner (hirerunner.co): Recruiting and talent placement platform for inclusive companies SoleSafe (solesafe.co): Insurance platform for collectibles/sneakers Decision Process With three GPs, Tundra operates as a partnership. The partners bring complementary expertise: healthcare/medtech (Choe), legal/corporate (Heyman), and accelerator/operations (Steer). Applications are accepted through the firm's website investment criteria page. Founder Preferences Tundra actively encourages applications from entrepreneurs who identify as BIPOC, women, non-binary, or LGBTQ+. Founders should demonstrate: self-awareness and personal integrity, growth mindset, relentlessness and grit, and unique founder-market fit. The firm values coachability (Midwestern grit and pragmatism) and looks for founders solving problems for overlooked end users. Anti-Thesis Tundra does not invest in Class II or Class III medical devices. The firm avoids companies without an MVP or defensible IP and does not appear to invest in hardware, deep tech R&D plays, or pre-revenue pure science companies.